Business Segments · Adjustments due to finalization of purchase price allocations
Biotechnology — Adjustments due to finalization of purchase price allocations
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2021
Last reportedQ4 2025
How to read this metric
An increase indicates a revision of initial acquisition estimates, while a zero value suggests that the initial purchase price allocation was finalized without further adjustments.
Detailed definition
This metric represents the net adjustments made to the fair value of assets and liabilities acquired in a business combi...
Peer comparison
Similar to 'Measurement Period Adjustments' or 'Purchase Price Allocation Revisions' found in the footnotes of M&A-active companies.
Metric ID:
dhr_segment_biotechnology_adjustments_due_to_finalization_of_purchase_price_allocationsHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $500.00K | $500.00K | $500.00K | $500.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | — | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — |
Range$0.00 – $500.00K
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's biotechnology — adjustments due to finalization of purchase price allocations?
- Danaher (DHR) reported biotechnology — adjustments due to finalization of purchase price allocations of $0.00 in Q4 2025.
- What does biotechnology — adjustments due to finalization of purchase price allocations mean?
- The final adjustments made to the recorded value of assets and liabilities acquired in a business merger after the initial valuation period.